January 13, 2023 – An Illinois-based Artificial Intelligence (AI) producer that offers actionable medical advice through biometric monitoring has showcased its pioneering tech solutions for the first time at CES 2023 — an industry event that’s widely recognized as the most influential in the world.
From January 5th-8th, AI Nexus Healthcare, based in Champaign, Illinois, joined some of the globe’s most influential technology brands to exhibit its signature technology, mia, which utilizes hybrid and explainable AI to offer real time, actionable medical advice to its users by replicating the diagnostic approach of a clinician.
With highly experienced AI specialist and CEO, Faramarz Farhoodi at the helm, AI Nexus Healthcare welcomed visitors from all over the world to explore and engage with its technology — demonstrating not only how far the brand has come, but also the ground-breaking solutions it has to offer.
In the company of industry leaders such as Microsoft, Intel and Samsung, this marked a significant milestone in the brand’s journey — marking its first global event and a significant step towards its ultimate goal of tackling wider healthcare issues.
Owned and produced by the Consumer Technology Association, CTA, CES 2023 offered attendees the chance to experience new technologies from global brands, hear about the future of technology from thought leaders and collaborate face-to-face with other attendees.
By taking insights from machine learning applied to vast amounts of data collected via scanning a fingertip or face using a smartphone and combining it with the input of dozens of medical experts across an array of health disciplines, mia, AI Nexus Healthcare’s signature platform, is able to predict the likelihood of adverse health events even before symptoms are present.
This signature software offers a comprehensive suite of applications designed to empower its users to take control of their health and to provide real-time decision support to healthcare professionals.